Product Information
HALOPERIDOL DEC 500 MG/5 ML VL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $15.5981 per ML under NDC 00143929601. Its NADAC has been published 348 times since Feb 5, 2020.
FDA first approved this application on Sep 28, 1998. Its Orange Book therapeutic-equivalence code is AO.
Strength
100 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143929601
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA075305FDA Approved
9/28/1998
TE Code
AO
On Market Since
10/1/1998
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has been published 348 times since Feb 5, 2020, and over the history we have for it it has declined 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.5981 per ML |
|---|---|
| All-time high | $39.9272 (Aug 12, 2020) |
| All-time low | $12.9792 (Jul 22, 2026) |
| 52-week high | $15.5981 |
| 52-week low | $12.9792 |
| Median price | $24.3320 |
| Average price | $24.7452 |
| Largest weekly change | +35.5% (Aug 18, 2021) |
| Weeks tracked | 348 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol Decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 500 MG/5 ML VL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 500 MG/5 ML VL, manufactured by Hikma Pharmaceuticals USA Inc., is $15.5981 per ML (NDC 00143929601), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 500 MG/5 ML VL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has declined 58.9%. It has been tracked across 348 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 500 MG/5 ML VL?
Since Feb 5, 2020, the NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has ranged from a low of $12.9792 (Jul 22, 2026) to a high of $39.9272 (Aug 12, 2020), with a median of $24.3320 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 500 MG/5 ML VL?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 100 MG/ML VIAL, is $7.5241 per ML — about 52% below HALOPERIDOL DEC 500 MG/5 ML VL.
Who manufactures HALOPERIDOL DEC 500 MG/5 ML VL?
HALOPERIDOL DEC 500 MG/5 ML VL (NDC 00143929601) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.